{"id":99362,"date":"2025-11-11T11:58:21","date_gmt":"2025-11-11T11:58:21","guid":{"rendered":"https:\/\/indianweekend.in\/index.php\/2025\/11\/11\/fredun-pharmaceuticals-reports-61-percent-yoy-growth-in-ebitda-to-inr-39-33-cr-in-h1-fy26\/"},"modified":"2025-11-11T11:58:21","modified_gmt":"2025-11-11T11:58:21","slug":"fredun-pharmaceuticals-reports-61-percent-yoy-growth-in-ebitda-to-inr-39-33-cr-in-h1-fy26","status":"publish","type":"post","link":"https:\/\/indianweekend.in\/index.php\/2025\/11\/11\/fredun-pharmaceuticals-reports-61-percent-yoy-growth-in-ebitda-to-inr-39-33-cr-in-h1-fy26\/","title":{"rendered":"Fredun Pharmaceuticals Reports 61 percent YoY Growth in EBITDA to INR 39.33 Cr in H1 FY26"},"content":{"rendered":"
\n

Mumbai (Maharashtra) [India], November 11:<\/strong> Fredun Pharmaceuticals Limited (BSE \u2013 FREDUN | 539730), is one of the Leading Pharmaceuticals Formulation manufacturing companies in India. Diversified into Generics, Cosmeceuticals, Nutraceuticals, Mobility and animal healthcare products, has reported its Unaudited financials for Q2 FY26 & H1 FY26.<\/p>\n

Key Financial Highlights<\/strong><\/p>\n

Q2 FY26 Standalone Financial Highlights<\/strong><\/p>\n

\u2022\u00a0Total Income of\u00a0\u20b9\u00a0145.29 Cr, YoY growth of 35.34%<\/p>\n

\u2022\u00a0EBITDA of\u00a0\u20b9\u00a022.34 Cr, YoY growth of 60.09%<\/p>\n

\u2022\u00a0EBITDA Margin\u00a0(%)\u00a0of 15.37%, YoY growth of 238 Bps<\/p>\n

\u2022\u00a0Net Profit of\u00a0\u20b9\u00a09.73 Cr, YoY growth of 127.75%<\/p>\n

\u2022\u00a0Net Profit\u00a0Margin\u00a0(%) of 6.70%, YoY growth of 272 Bps<\/p>\n

\u2022\u00a0EPS of\u00a0\u20b9\u00a020.61, YoY growth of 127.73%<\/p>\n

H1 FY26 Standalone Financial Highlights<\/strong><\/p>\n

\u2022\u00a0Total Income of\u00a0\u20b9\u00a0265.15 Cr, YoY growth of 42.43%<\/p>\n

\u2022\u00a0EBITDA of\u00a0\u20b9\u00a039.33 Cr, YoY growth of 60.98%<\/p>\n

\u2022\u00a0EBITDA Margin of 14.83%, YoY growth of 171\u00a0Bps<\/p>\n

\u2022\u00a0Net Profit of\u00a0\u20b9\u00a016.50 Cr, YoY growth of 96.33%<\/p>\n

\u2022\u00a0Net Profit\u00a0Margin\u00a0(%) of 6.22%, YoY growth of 171\u00a0Bps<\/p>\n

\u2022\u00a0EPS of\u00a0\u20b9\u00a034.94, YoY growth of 96.29%<\/p>\n

Commenting on the\u00a0financial\u00a0performance\u00a0Mr. Fredun Medhora, Managing Director, said,\u00a0\u201cQ2 FY26 was a strong quarter for Fredun, driven by consistent growth across our pharmaceutical and pet care verticals. Our domestic formulations segment continued to deliver solid performance through new product introductions and expanding institutional demand, while exports maintained steady traction.<\/p>\n

We have commenced expansion of our state-of-the-art manufacturing facility at Palghar to enhance capacity, improve operational efficiency, and support the growing demand across both domestic and internationalmarkets.<\/p>\n

The past few months have been pivotal in shaping Fredun\u2019s position as a first mover in India\u2019s organized pet healthcare space. The launch of Snacky Jain\u2014India\u2019s first Jain functional food for pets\u2014received an overwhelming response, with the entire first batch sold out through pre-orders. Backed by robust capacity, strong retail partnerships, and growing presence across eight states, this launch reinforces our ethical and research-led approach to pet nutrition.\u00a0Our acquisitions of Wagr.ai and One Pet Stop have expanded our footprint across nutrition, technology, and services\u2014creating a truly connected and science-driven pet care ecosystem. This integrated approach positions us uniquely at the intersection of healthcare, nutrition, and technology in a market poised for exponential growth.\u00a0We reported improved cash flows this quarter, driven by efficient execution and disciplined operations.<\/p>\n

Looking ahead, we aim to scale our operations, accelerate new product launches, and strengthen our digital-first platforms to enhance accessibility and experience for pet parents. With a clear strategy, strong execution, and first-mover advantage, we remain confident of sustaining our growth momentum and building long-term value for all\u201d<\/p>\n

Key Business Highlights<\/strong><\/p>\n\n\n\n\n\n\n
Preferential Issue of Securities<\/td>\n\u2022\u00a0Type:\u00a0Equity Shares (6,52,360) and Convertible Warrants (5,73,600)<\/p>\n

\u2022\u00a0Face Value:\u00a0Rs. 10 per Equity Share\/Warrant<\/p>\n

\u2022\u00a0Issue Price:\u00a0Rs. 1,250 per Equity Share\/Warrant<\/p>\n<\/td>\n<\/tr>\n

Declaration of Final Dividend<\/td>\n\u2022\u00a0Dividend Rate:\u00a07% on equity shares<\/p>\n

\u2022\u00a0Face Value:\u00a0\u20b910 per share<\/p>\n<\/td>\n<\/tr>\n

Strategic Acquisitions<\/td>\n\u2022\u00a0Wagr.ai:\u00a0A leading pet-tech platform offering an AI-driven ecosystem for pet products & services.<\/p>\n

\u2022\u00a0One Pet Stop Pvt. Ltd:\u00a0A pet grooming and wellness services provider offering tech-enabled doorstep grooming.<\/p>\n<\/td>\n<\/tr>\n

New Product Launch<\/td>\n\u2022 Snacky Jain: India\u2019s first 100% Jain-compliant functional food for pets, made with natural, plant-based ingredients to support overall pet health and wellness<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.<\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Mumbai (Maharashtra) [India], November 11: Fredun Pharmaceuticals Limited (BSE \u2013 FREDUN | 539730), is one of the Leading Pharmaceuticals Formulation manufacturing companies in India. Diversified into Generics, Cosmeceuticals, Nutraceuticals, Mobility and animal healthcare products, has reported its Unaudited financials for Q2 FY26 & H1 FY26. Key Financial Highlights Q2 FY26 Standalone Financial Highlights \u2022\u00a0Total Income […]<\/p>\n","protected":false},"author":1,"featured_media":99363,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[116],"tags":[19],"class_list":["post-99362","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-business"],"_links":{"self":[{"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/posts\/99362","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/comments?post=99362"}],"version-history":[{"count":0,"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/posts\/99362\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/media\/99363"}],"wp:attachment":[{"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/media?parent=99362"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/categories?post=99362"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/tags?post=99362"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}